title: Advantages of using tetrahydrofuran-water as mobile phases in the quantitation of cyclosporin A in monkey and rat plasma by liquid chromatography-tandem mass spectrometry.
abstract: A new analytical method is described here for the quantitation of anti-inflammatory drug cyclosporin A (CyA) in monkey and rat plasma. The method used tetrahydrofuran (THF)-water mobile phases to elute the analyte and internal standard, cyclosporin C (CyC). The gradient mobile phase program successfully eluted CyA into a sharp peak and therefore improved resolution between the analyte and possible interfering materials compared with previously reported analytical approaches, where CyA was eluted as a broad peak due to the rapid conversion between different conformers. The sharp peak resulted from this method facilitated the quantitative calculation as multiple smoothing and large number of bunching factors were not necessary. The chromatography in the new method was performed at 30 degrees C instead of 65-70 degrees C as reported previously. Other advantages of the method included simple and fast sample extraction-protein precipitation, direct injection of the extraction supernatant to column for analysis, and elimination of evaporation and reconstitution steps, which were needed in solid phase extraction or liquid-liquid extraction reported before. This method is amenable to high-throughput analysis with a total chromatographic run time of 3 min. This approach has been verified as sensitive, linear (0.977-4000 ng/mL), accurate and precise for the quantitation of CyA in monkey and rat plasma. However, compared with the usage of conventional mobile phases, the only drawback of this approach was the reduced detection response from the mass spectrometer that was possibly caused by poor desolvation in the ionization source. This is the first report to demonstrate the advantages of using THF-water mobile phases to elute CyA in liquid chromatography.
authors.affiliation: Covance Laboratories Inc., 3301 Kinsman Boulevard, Madison, WI, USA. cong-jun.li@covance.com
authors.forename: Austin C
authors.initials: AC
authors.lastname: Li
authors.forename: Yinghe
authors.initials: Y
authors.lastname: Li
authors.forename: Micheal S
authors.initials: MS
authors.lastname: Guirguis
authors.forename: Robert G
authors.initials: RG
authors.lastname: Caldwell
authors.forename: Wilson Z
authors.initials: WZ
authors.lastname: Shou
mesh_terms: D000818:Animals; D019540:Area Under Curve; D002138:Calibration; D002853:Chromatography, Liquid; D016572:Cyclosporine / Q000097:blood* / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D005663:Furans; D007166:Immunosuppressive Agents / Q000097:blood* / Q000493:pharmacokinetics; D008252:Macaca fascicularis; D008297:Male; D013058:Mass Spectrometry; D011786:Quality Control; D051381:Rats; D012015:Reference Standards; D015203:Reproducibility of Results; D014867:Water
chemical_list: D005663:Furans; D007166:Immunosuppressive Agents; D014867:Water; C018674:tetrahydrofuran; D016572:Cyclosporine